These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 412161)

  • 21. [Diagnostic and therapeutic measures in materno-fetal Rh-factor isoimmunization].
    Paladini A; Di Martino D; De Luca P; Rascio B; Di Lieto A
    Arch Ostet Ginecol; 1969 Dec; 74(6):476-94. PubMed ID: 5000274
    [No Abstract]   [Full Text] [Related]  

  • 22. [Physiopathology and treatment of fetal hydrops caused by Rh blood group incompatibility].
    David G; Larroche JC; Maigret P; Lacomme M
    Bibl Gynaecol; 1966; 38():114-45. PubMed ID: 4957981
    [No Abstract]   [Full Text] [Related]  

  • 23. [Spectrophotometry of the amniotic fluid in rhesus incompatibility].
    Baumgarten K; Fröhlich H
    Wien Med Wochenschr; 1968 Jun; 118(22):499-503. PubMed ID: 4974975
    [No Abstract]   [Full Text] [Related]  

  • 24. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 25. [Icterus gravis and exchange transfusion].
    Tulzer W; Griebler T
    Wien Med Wochenschr; 1967 Apr; 117(13):334-7. PubMed ID: 4968441
    [No Abstract]   [Full Text] [Related]  

  • 26. Rhesus anti-E, anti-c antibodies as a cause of hemolytic disease of the newborn.
    Nair PM; Sabarinathan K; Jayaprakash PA; Vijayalekshmi
    Indian Pediatr; 1983 Sep; 20(9):681-4. PubMed ID: 6427106
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fetomaternal transfusion, Rhesus immunization and prevention. II. Rhesus immunization and prevention].
    Helderweirt G
    Verh K Acad Geneeskd Belg; 1976; 38(3-4):79-134. PubMed ID: 826036
    [No Abstract]   [Full Text] [Related]  

  • 28. [Remote after-effects of hemolytic diseases in newborn, caused by the ABO- and Rh-incompatibility in the blood of mother and fetus].
    Nersisian VM
    Zh Eksp Klin Med; 1969; 9(5):82-5. PubMed ID: 4988140
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 30. [Serologic incompatibility with regard to Rh factor in parents and between mother and fetus and its consequences in the years 1960-1968].
    Tompolski C; Walkiewicz T
    Pol Tyg Lek; 1970 May; 25(18):633-5. PubMed ID: 4988061
    [No Abstract]   [Full Text] [Related]  

  • 31. Multiple maternal isoimmunization.
    Cardwell MS
    J Tenn Med Assoc; 1988 Jul; 81(7):435-6. PubMed ID: 3135450
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of a full-term infant with hemolytic disease of the newborn due to an anti-Rh17 antibody in a mother with D-- phenotype.
    Shah SI; Caprio M; Strauss R; Moskowitz N
    Am J Hematol; 2005 Sep; 80(1):88-9. PubMed ID: 16138349
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnosis, prevention, and therapy in hemolytic disease of the newborn.
    Polesky HF
    Clin Lab Med; 1982 Mar; 2(1):107-22. PubMed ID: 6821161
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prenatal blood transfusions for anti-D-erythroblastosis in twin pregnancies (author's transl)].
    Schultze-Mosgau H; Fischer K; Poschmann A; Berle P
    Med Klin; 1974 Jan; 69(3):94-6. PubMed ID: 4206040
    [No Abstract]   [Full Text] [Related]  

  • 35. [The technic of intrauterine fetal transfusion in cases of severe isoimmunization due to Rh-incompatibility].
    Iordanov I
    Akush Ginekol (Sofiia); 1974; 13(6):435-9. PubMed ID: 4219717
    [No Abstract]   [Full Text] [Related]  

  • 36. An assessment of intra-uterine foetal tranfusion.
    Connon AF; Hay JA; Kneebone GM; Jones GH; Stentiford HB
    Med J Aust; 1967 Jul; 2(3):93-7. PubMed ID: 4961911
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnostic and therapeutic possibilities in incompatibility processes].
    Kozlowski P
    Gynakologe; 1990 Jun; 23(3):172-7. PubMed ID: 2117563
    [No Abstract]   [Full Text] [Related]  

  • 38. [Intrauterine transfusion in severe fetal erythroblastosis. Results and methods--studies of 803 cases of the world literature].
    Pfleiderer A; Goblirsch H
    Med Welt; 1969 Feb; 5():232-7. PubMed ID: 4978482
    [No Abstract]   [Full Text] [Related]  

  • 39. [Neonatal thrombocytopenic purpura and hemolytic disease caused by Rh incompatibility in the female first-born infant of a transfused mother].
    Pecorella F; Balsamo V; Collica F
    Haematologica; 1966; 51(6):453-84. PubMed ID: 4959216
    [No Abstract]   [Full Text] [Related]  

  • 40. [Obstetrical indications in erythroblastosis of the newborn due to Rh incompatibility].
    SIEBERTS H; POTHMANN FJ
    Med Klin; 1952 Mar; 47(13):407-9. PubMed ID: 14940608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.